Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Falk

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
Phase II study of carboplatin and adriamycin as second line chemotherapy in small cell lung cancerS J Falk, T S Maughan, V M Laurence, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancerJ R Ramsay, N M Bleehen, I Dennis, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1997
A short fractionation radiotherapy treatment for poor prognosis patients with high grade gliomaJ M Ford, S P Stenning, D J Boote, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2008
Maximising recruitment into randomised controlled trials: the role of multidisciplinary cancer teamsA G K McNair, C T P Choh, C Metcalfe, et al.
British Journal of Cancer|August 17, 2000
Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung CancerH Anderson, P Hopwood, R J Stephens, et al.
British Journal of Cancer|June 13, 2014
Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancerJ M Blazeby, S Strong, J L Donovan, et al.
British Journal of Cancer|July 24, 2015
Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancerJ Rees, C N Hurt, S Gollins, et al.
Lancet (London, England)|January 8, 2013
Understanding surgical interventions in RCTs: the need for better methodologyK N Avery, C P Barham, R Berrisford, et al.
British Journal of Cancer|May 9, 2013
Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factorsR Cooke, M E Jones, D Cunningham, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
Phase II study of carboplatin and adriamycin as second line chemotherapy in small cell lung cancerS J Falk, T S Maughan, V M Laurence, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancerJ R Ramsay, N M Bleehen, I Dennis, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1997
A short fractionation radiotherapy treatment for poor prognosis patients with high grade gliomaJ M Ford, S P Stenning, D J Boote, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2008
Maximising recruitment into randomised controlled trials: the role of multidisciplinary cancer teamsA G K McNair, C T P Choh, C Metcalfe, et al.
British Journal of Cancer|August 17, 2000
Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung CancerH Anderson, P Hopwood, R J Stephens, et al.
British Journal of Cancer|June 13, 2014
Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancerJ M Blazeby, S Strong, J L Donovan, et al.
British Journal of Cancer|July 24, 2015
Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancerJ Rees, C N Hurt, S Gollins, et al.
Lancet (London, England)|January 8, 2013
Understanding surgical interventions in RCTs: the need for better methodologyK N Avery, C P Barham, R Berrisford, et al.
British Journal of Cancer|May 9, 2013
Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factorsR Cooke, M E Jones, D Cunningham, et al.
Pageof 2